Cargando…
Could DIZE be the answer to COVID-19?
Autores principales: | Qaradakhi, Tawar, Gadanec, Laura, Matsoukas, John, Apostolopoulos, Vasso, Zulli, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331507/ https://www.ncbi.nlm.nih.gov/pubmed/32636103 http://dx.doi.org/10.1016/j.maturitas.2020.07.002 |
Ejemplares similares
-
Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
por: Kate Gadanec, Laura, et al.
Publicado: (2021) -
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
por: Gadanec, Laura Kate, et al.
Publicado: (2021) -
The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease
por: Qaradakhi, Tawar, et al.
Publicado: (2020) -
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
por: McSweeney, Kristen Renee, et al.
Publicado: (2021) -
Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)